Survival in Lung Cancer in the Nordic Countries Through A Half Century

Figures & data

Table 1 Age-Standardized Incidence (A) and Mortality (B) in Lung Cancer per 100,000 from 2011 to 2020, Separately for Males (Left Part) and Females (Right Part)

Males	ASR (World)	Cum. risk % [0–74]	Females	ASR (World)	Cum. Risk % [0–74]
A) Case numbers
Denmark, 23,843	38.5	4.7	Denmark, 23,889	36.5	4.6
Finland, 17,493	28.2	3.5	Finland, 10,133	14.0	1.8
Norway, 16,561	32.1	3.9	Norway, 14,924	27.5	3.6
Sweden, 20,026	17.8	2.2	Sweden, 21,817	19.0	2.5
B) Death numbersity
Denmark, 18,727	28.9	3.3	Denmark, 17,755	24.7	3.0
Finland, 14,604	22.8	2.8	Finland, 7771	10.0	1.3
Norway, 11,896	22.3	2.6	Norway, 9878	16.9	2.1
Sweden, 18,125	15.0	1.7	Sweden, 18,205	14.1	1.8

Figure 1 Relative 1-, 5/1- and 5-year survival rates of lung cancer in Denmark (a and e), Finland (b and f), Norway (c and g) and Sweden (d and h), separately for males (a–d) and females (e–h). The vertical lines mark a detectable change in the survival trends (“breaking points”) and the bottom curves show estimated annual changes in survival. The curves are solid if there is >95% plausibility that the curve grows or declines. Shadow areas indicate 95% credible interval derived from GAM. All curves are color coded (see the insert).

Table 2 1-Year (a) and 5-Year (b) Relative Survival % [95% Confidence Interval] in Lung Cancer from 1971 to 2020, Separately for Males (Left) and Females (Right)

	Male Cancers				Female Cancers
	Denmark	Finland	Norway	Sweden	Denmark	Finland	Norway	Sweden
(a) 1-year
1971–1975	25.5 [24.3–26.7]	34.7 [33.4–36.0]*	26.4 [24.6–28.3]*	25.0 [23.9–26.1]*	24.1 [22.1–26.3]	34.5 [31.3–37.9]	29.4 [26.2–33.1]	26.6 [24.7–28.7]*
1976–1980	25.0 [24.0–26.0]	38.3 [37.2–39.5]	30.1 [28.5–31.7]	28.6 [27.5–29.8]*	25.0 [23.4–26.8]	39.6 [36.9–42.6]	32.0 [29.1–35.2]	32.5 [30.5–34.7]
1981–1985	24.3 [23.3–25.2]	39.2 [38.1–40.4]	30.7 [29.3–32.2]	31.3 [30.1–32.4]	24.6 [23.3–26.1]	41.4 [38.9–44.2]	29.4 [27.1–32.0]	34.5 [32.7–36.4]
1986–1990	24.4 [23.4–25.3]	37.1 [35.9–38.3]	29.2 [27.9–30.5]	30.8 [29.6–31.9]	25.4 [24.2–26.7]	40.5 [38.1–43.0]	30.7 [28.6–32.8]	32.3 [30.7–34.0]*
1991–1995	24.7 [23.8–25.7]*	33.9 [32.8–35.1]	29.3 [28.1–30.7]*	31.4 [30.3–32.6]*	25.9 [24.8–27.1]*	38.3 [36.2–40.6]	34.2 [32.3–36.1]	35.6 [34.1–37.1]*
1996–2000	26.9 [26.0–27.9]*	35.8 [34.6–37.1]	32.0 [30.8–33.3]	34.1 [33.0–35.4]*	30.3 [29.2–31.4]*	40.9 [38.9–43.0]	33.6 [32.0–35.3]*	39.4 [38.0–40.9]*
2001–2005	32.2 [31.2–33.2]*	36.8 [35.6–38.1]	33.6 [32.3–34.9]*	38.0 [36.8–39.2]*	35.5 [34.4–36.6]*	43.6 [41.7–45.6]	38.8 [37.3–40.4]*	43.5 [42.2–44.7]*
2006–2010	34.8 [33.8–35.9]*	36.1 [34.8–37.4]*	39.2 [37.9–40.5]*	41.8 [40.6–43.0]*	40.6 [39.5–41.6]*	46.2 [44.4–48.0]	44.4 [43.0–45.8]*	47.3 [46.1–48.5]*
2011–2015	42.7 [41.6–43.8]*	39.0 [37.7–40.3]*	44.9 [43.6–46.2]*	47.0 [45.8–48.2]*	50.9 [49.9–52.0]*	48.5 [46.9–50.2]*	53.5 [52.2–54.9]*	54.9 [53.8–56.1]*
2016–2020	52.0 [50.8–53.1]	43.0 [41.7–44.3]	53.1 [51.8–54.5]	52.7 [51.5–54.0]	60.2 [59.2–61.3]	52.4 [50.8–54.1]	59.7 [58.4–61.1]	60.1 [59.0–61.2]
(b) 5-years
1971–1975	8.1 [7.3–9.0]	7.5 [6.8–8.3]	6.9 [5.8–8.2]	8.8 [8.1–9.6]	8.0 [6.6–9.7]	10.3 [8.2–12.9]	9.4 [7.1–12.5]	10.9 [9.5–12.5]
1976–1980	7.3 [6.7–8.0]	8.1 [7.5–8.8]*	7.5 [6.5–8.5]	8.7 [7.9–9.5]	6.9 [5.9–8.1]	12.4 [10.6–14.5]	11.7 [9.7–14.1]	13.2 [11.7–15.0]
1981–1985	5.8 [5.2–6.4]	9.9 [9.1–10.7]	7.8 [6.9–8.8]	8.7 [8.0–9.5]	6.2 [5.5–7.1]	13.1 [11.3–15.1]	7.1 [5.8–8.7]	13.2 [11.9–14.6]
1986–1990	6.5 [6.0–7.1]	9.7 [9.0–10.6]	8.1 [7.3–9.1]	9.5 [8.8–10.3]	6.4 [5.7–7.2]	13.2 [11.5–15.1]	9.7 [8.4–11.3]	11.4 [10.3–12.6]*
1991–1995	6.6 [6.0–7.2]*	8.4 [7.7–9.2]	8.8 [8.0–9.7]	9.9 [9.2–10.7]	6.8 [6.1–7.6]*	13.4 [11.9–15.2]	11.6 [10.3–13.1]	14.1 [13.0–15.2]
1996–2000	7.9 [7.3–8.6]	9.7 [9.0–10.6]	9.7 [8.8–10.6]	11.3 [10.5–12.2]	9.0 [8.2–9.7]*	15.6 [14.1–17.3]	12.8 [11.6–14.1]	15.6 [14.6–16.7]
2001–2005	9.0 [8.3–9.7]*	10.2 [9.4–11.1]	11.2 [10.3–12.1]*	12.5 [11.7–13.4]*	11.2 [10.5–12.0]*	14.9 [13.5–16.4]	14.6 [13.5–15.9]*	16.5 [15.6–17.5]*
2006–2010	11.7 [11.0–12.5]*	9.8 [9.0–10.7]*	13.9 [13.0–15.0]*	15.1 [14.1–16.1]*	14.6 [13.9–15.5]*	17.2 [15.8–18.7]*	18.5 [17.3–19.7]*	19.5 [18.6–20.5]*
2011–2015	16.6 [15.8–17.5]*	13.5 [12.5–14.5]*	19.8 [18.7–21.0]*	18.9 [17.9–19.9]*	23.1 [22.2–24.0]*	20.8 [19.4–22.3]*	26.7 [25.5–28.0]*	25.0 [24.0–26.1]*
2016–2020	23.8 [22.8–25.0]	16.4 [15.2–17.6]	26.6 [25.3–28.0]	23.9 [22.7–25.1]	30.6 [29.5–31.8]	25.5 [23.8–27.2]	33.2 [31.8–34.6]	31.0 [29.8–32.2]

Note: *Significant (non-overlapping 95% CLs) increase between the marked and the next period.

Table 3 5/1-Year (4-Year Conditional) Survival % in Lung Cancer from 1971 to 2020, Separately for Males (Left) and Females (Right)

	Male Cancers				Female Cancers
	Denmark	Finland	Norway	Sweden	Denmark	Finland	Norway	Sweden
1971–1975	31.8	21.6	26.1	35.2	33.2	29.9	32.0	41.0
1976–1980	29.2	21.1	24.9	30.4	27.6	31.3	36.6	40.6
1981–1985	23.9	25.3	25.4	27.8	25.2	31.6	24.1	38.3
1986–1990	26.6	26.1	27.7	30.8	25.2	32.6	31.6	35.3
1991–1995	26.7	24.8	30.0	31.5	26.3	35.0	33.9	39.6
1996–2000	29.4	27.1	30.3	33.1	29.7	38.1	38.1	39.6
2001–2005	28.0	27.7	33.3	32.9	31.5	34.2	37.6	37.9
2006–2010	33.6	27.1	35.5	36.1	36.0	37.2	41.7	41.2
2011–2015	38.9	34.6	44.1	40.2	45.4	42.9	49.9	45.5
2016–2020	45.8	38.1	50.1	45.4	50.8	48.7	55.6	51.6